Altria’s robust pricing strategy for smokable products, gains from smoke-free segment in focus during Q4 earnings
Altria (NYSE:MO) is set to report fourth quarter earnings on Thursday, and investors will focus on the tobacco giant’s ...
The Associated Press - Business News on MSN13d
FDA Authorizes Zyn Nicotine Pouches
Philip Morris has stated it does not employ online influencers or endorsements to promote Zyn, which is marketed in the U.S.
ABC712d
FDA approves Zyn nicotine pouches, citing health benefits for adult smokers
The newest nicotine product comes in multiple different flavors and is growing in popularity among teenagers. Zen is *** tiny ...
Altria Group (MO) Expected to Announce Earnings on Thursday
Altria Group (NYSE:MO – Get Free Report) is projected to issue its quarterly earnings data before the market opens on ...
kcra.com13d
FDA approves Zyn nicotine pouches, citing health benefits for adult smokers
It competes with similar products from other tobacco competitors, including Altria’s On pouches. Federal health officials on Thursday backed the public health benefits of nicotine pouches ...
NBC 6 South Florida13d
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
which is marketed in the U.S. by its Swedish Match unit. It competes with similar products from other tobacco competitors, including Altria’s On pouches.
Newsday13d
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
For decades, tobacco companies have tried to develop ... The product competes with similar ones from competitors, including Altria’s On pouches. Newsday's Gregg Sarra hosts a new show covering ...
The Boston Globe13d
FDA approves sales of Zyn nicotine pouches, citing health benefits for adult smokers
It competes with similar products from other tobacco competitors, including Altria’s On pouches. The Associated Press Health and Science Department receives support from the Howard Hughes ...